Log in

NASDAQ:CUTR - Cutera Stock Price, Forecast & News

$12.62
-1.20 (-8.68 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
$12.38
Now: $12.62
$13.85
50-Day Range
$9.19
MA: $21.60
$28.68
52-Week Range
$9.07
Now: $12.62
$39.15
Volume174,641 shs
Average Volume255,726 shs
Market Capitalization$181.98 million
P/E RatioN/A
Dividend YieldN/A
Beta1.24
Cutera, Inc., a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. It also provides excel V, a vascular and benign pigmented lesion treatment platform; xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; Juliet, a laser system for vaginal health; and Secret RF, a fractional radio frequency microneedling device for skin revitalization. In addition, the company offers GenesisPlus, CoolGlide, myQ, enlighten SR, and truSculpt iD products. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills and marketing brochures through the Internet. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, physicians performing aesthetic treatments in non-medical offices, and other qualified practitioners, as well as for physicians offering aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.
Read More
Cutera logo

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:CUTR
CUSIPN/A
Phone415-657-5500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$181.71 million
Book Value$3.23 per share

Profitability

Net Income$-12,350,000.00

Miscellaneous

Employees402
Market Cap$181.98 million
Next Earnings Date5/14/2020 (Estimated)
OptionableOptionable

Receive CUTR News and Ratings via Email

Sign-up to receive the latest news and ratings for CUTR and its competitors with MarketBeat's FREE daily newsletter.


Cutera (NASDAQ:CUTR) Frequently Asked Questions

How has Cutera's stock been impacted by COVID-19 (Coronavirus)?

Cutera's stock was trading at $18.11 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CUTR shares have decreased by 30.3% and is now trading at $12.62. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Cutera?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Cutera.

When is Cutera's next earnings date?

Cutera is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Cutera.

How were Cutera's earnings last quarter?

Cutera, Inc. (NASDAQ:CUTR) announced its quarterly earnings data on Wednesday, February, 26th. The medical device company reported ($0.15) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by $0.17. The medical device company had revenue of $51.80 million for the quarter. Cutera had a negative return on equity of 28.68% and a negative net margin of 6.80%. View Cutera's earnings history.

What guidance has Cutera issued on next quarter's earnings?

Cutera issued an update on its FY 2020 After-Hours earnings guidance on Wednesday, February, 26th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $194-200 million, compared to the consensus revenue estimate of $194.85 million.

What price target have analysts set for CUTR?

3 analysts have issued 1 year price targets for Cutera's shares. Their forecasts range from $15.00 to $15.00. On average, they anticipate Cutera's stock price to reach $15.00 in the next twelve months. This suggests a possible upside of 18.9% from the stock's current price. View analysts' price targets for Cutera.

Has Cutera been receiving favorable news coverage?

News headlines about CUTR stock have trended somewhat negative on Saturday, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cutera earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave media stories about the medical device company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutCutera.

Are investors shorting Cutera?

Cutera saw a drop in short interest in March. As of March 13th, there was short interest totaling 624,500 shares, a drop of 8.4% from the February 27th total of 681,600 shares. Based on an average trading volume of 172,100 shares, the short-interest ratio is presently 3.6 days. Approximately 4.6% of the company's shares are short sold. View Cutera's Current Options Chain.

Who are some of Cutera's key competitors?

What other stocks do shareholders of Cutera own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include AbbVie (ABBV), Micron Technology (MU), Advanced Micro Devices (AMD), Gilead Sciences (GILD), Alibaba Group (BABA), Pfizer (PFE), Costco Wholesale (COST), NVIDIA (NVDA), QUALCOMM (QCOM) and Roku (ROKU).

Who are Cutera's key executives?

Cutera's management team includes the following people:
  • Ms. Sandra A. Gardiner, Exec. VP & CFO (Age 53)
  • Mr. Larry E. Laber, Exec. VP of Sales - North America (Age 48)
  • Mr. Ronald J. Santilli, Exec. Officer (Age 59)
  • Mr. Jason Richey, Interim CEO & Chief Operating Officer
  • Dr. Michael Karavitis, Exec. VP & Chief Technology Officer

What is Cutera's stock symbol?

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

Who are Cutera's major shareholders?

Cutera's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Victory Capital Management Inc. (7.37%), Victory Capital Management Inc. (4.81%), Gabelli Funds LLC (4.35%), State Street Corp (3.65%), Kennedy Capital Management Inc. (1.82%) and Acadian Asset Management LLC (1.58%). Company insiders that own Cutera stock include David A Gollnick, David H Mowry, Gregory A Barrett, J Daniel Plants, James A Reinstein and Larry Laber. View institutional ownership trends for Cutera.

Which major investors are selling Cutera stock?

CUTR stock was sold by a variety of institutional investors in the last quarter, including Archon Capital Management LLC, EAM Global Investors LLC, Gabelli Funds LLC, Kennedy Capital Management Inc., Raymond James & Associates, Spark Investment Management LLC, EAM Investors LLC, and Wedge Capital Management L L P NC. View insider buying and selling activity for Cutera.

Which major investors are buying Cutera stock?

CUTR stock was bought by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Victory Capital Management Inc., Acadian Asset Management LLC, Calamos Advisors LLC, Russell Investments Group Ltd., Goldman Sachs Group Inc., State Street Corp, and Driehaus Capital Management LLC. Company insiders that have bought Cutera stock in the last two years include David H Mowry, Gregory A Barrett, J Daniel Plants, and James A Reinstein. View insider buying and selling activity for Cutera.

How do I buy shares of Cutera?

Shares of CUTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cutera's stock price today?

One share of CUTR stock can currently be purchased for approximately $12.62.

How big of a company is Cutera?

Cutera has a market capitalization of $181.98 million and generates $181.71 million in revenue each year. The medical device company earns $-12,350,000.00 in net income (profit) each year or ($0.88) on an earnings per share basis. Cutera employs 402 workers across the globe. View additional information about Cutera.

What is Cutera's official website?

The official website for Cutera is http://www.cutera.com/.

How can I contact Cutera?

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company can be reached via phone at 415-657-5500 or via email at [email protected]


MarketBeat Community Rating for Cutera (NASDAQ CUTR)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  296 (Vote Outperform)
Underperform Votes:  273 (Vote Underperform)
Total Votes:  569
MarketBeat's community ratings are surveys of what our community members think about Cutera and other stocks. Vote "Outperform" if you believe CUTR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CUTR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Featured Article: What are economic reports?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel